Last reviewed · How we verify
NCT05612308: VOP&SNAG
Vertical Oscillatory Pressure and Sustained Natural Apophyseal Glides in ow Back Pain
NA trial testing Vertical Oscillatory Pressure (VOP) in Non Specific Low Back Pain in 25 participants. Completed in 10 September 2022.
18 July 2022
Quick facts
| Lead sponsor | Obafemi Awolowo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 24 September 2021 |
| Primary completion | 18 July 2022 |
| Estimated completion | 10 September 2022 |
| Sites | 1 location across Nigeria |
Drugs / interventions tested
- Vertical Oscillatory Pressure (VOP)
Conditions studied
- Non Specific Low Back Pain — all drugs for Non Specific Low Back Pain →
Sponsor
Obafemi Awolowo University
Who can join
Adults 18 to 75, any sex, with Non Specific Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Among different spinal manual therapies, which have been reported to be effective in the management of LBP are Sustained Natural Apophyseal Glide (SNAGS) and Vertical Oscillatory Pressure (VOP) . Vertical oscillatory pressure is a derivative of manipulative therapy whereby a gentle vertical manipulative oscillation is applied on spinal vertebrae and has been noted to be effective in management of low back pain . On the contrary, the SNAGS is a manipulative technique that is commonly used in the western countries and found to be effective in reducing pain and disability in the management of mechanical LBP . However, there are limited studies comparing the effects of SNAG and VOP on clinical and psychosocial variables in patients with mechanical LBP in Nigeria. Hence, this study aims at investigating the effects of Nwugarian VOP and SNAG techniques on selected clinical and psychosocial variables in patients with mechanical LBP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05612308
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Obafemi Awolowo University trials
Trials by the same sponsor.
- NCT05321823 — Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigatio · NA · unknown
- NCT05832866 — Clinic-based and Tele-monitored Home-based Intervention in Patients With Knee OA · NA · completed
- NCT04466657 — Antioxidant Therapy for COVID-19 Study · NA · withdrawn
- NCT04459286 — The Nitazoxanide Plus Atazanavir for COVID-19 Study · Phase 2 · terminated
- NCT05680792 — Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05612308 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Obafemi Awolowo University
- Last refreshed: 10 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05612308.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing